
On Monday, Palantir Technologies Inc. (NASDAQ:PLTR) co-founder Joe Lonsdale urged a tech-driven transformation of the Food and Drug Administration, warning that bureaucratic inertia is putting the U.S. behind China in the biotech race.
What Happened: In a blog post, Lonsdale said the FDA's current systems are "sluggish" and outdated, slowing drug approvals and hampering innovation.